Abstract
We report a case of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder (HL-PTLD) after kidney transplantation to highlight the difficulty of distinguishing this disorder from Hodgkin lymphoma-like PTLD (HL-like PTLD). Through this case report and literature review, we seek to clarify definitive pathologic features to differentiate these two conditions. A 38-year-old male kidney transplant recipient who had been receiving immunosuppressants was admitted to our hospital with unidentified high fever. Computed tomography images and blood tests indicated a lymphoproliferative disorder. Abdominal lymph node biopsy was performed, and microscopic examination revealed the presence of many large atypical cells in a background of dense T cell accumulation. The large, atypical cells were positive for Epstein–Barr Virus (EBV)-encoded small RNAs (EBER) in situ hybridization, EBV-LMP1, CD30 and PAX5, but negative for CD15, CD20 and CD45. Except for CD15-negativity, this immunohistochemical pattern was consistent with that of classical Hodgkin lymphoma. By close examination of the above immunoreactivities and the patient’s subsequent chemosensitive clinical course, we finally made a diagnosis of HL-PTLD.
Similar content being viewed by others
References
Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 453–62.
Ranganathan S, Webber S, Ahuja S, Jaffe R. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol. 2004;7:348–60.
Rohr JC, Wagner HJ, Lauten M, Wacker HH, Jüttner E, Hanke C, et al. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transpl. 2008;12:426–31.
Pitman SD, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Berdeja JG, et al. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006;30:470–6.
Oldhafer KJ, Bunzendahl H, Frei U, Kemnitz J, Vogt P, Pichlmayr R. Primary Hodgkin’s lymphoma: an unusual cause of graft dysfunction after kidney transplantation. Am J Med. 1989;87:218–20.
Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993;72:2568–73.
Goyal RK, McEvoy L, Wilson DB. Hodgkin disease after renal transplantation in childhood. J Pediatr Hematol Oncol. 1996;18:392–5.
Lister J, Simpson JK, deMagalhaes-Silverman MM, Rybka WB, Donnenberg AD, Myers DJ, et al. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years. Bone Marrow Transpl. 1997;19:943–5.
Chetty R, Biddolph S, Gatter K. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin’s disease and Reed-Sternberg-like cells in non-Hodgkin’s lymphomas and reactive conditions. Hum Pathol. 1997;28:493–8.
Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin’s lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transpl. 2004;8:87–90.
Zambelli A, Lilleri D, Baldanti F, Scelsi M, Villani L, Da Prada GA. Hodgkin’s disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma. BMC Cancer. 2005;5:109.
Flanagan KH, Brennan DC. EBV-associated recurrent Hodgkin’s disease after renal transplantation. Transpl Int. 2006;19:338–41.
Choi JH, Ahn MJ, Oh YH, Han SW, Kim HJ, Lee YY, et al. Epstein–Barr virus-associated Hodgkin’s disease following renal transplantation. Korean J Intern Med. 2006;21:46–9.
Gheorghe G, Albano EA, Porter CC, McGavran L, Wei Q, Meltesen L, et al. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007;29:112–6.
Okuno K, Horie Y, Kanai K, Kato M, Kuwamoto S, Okazaki T, et al. Epstein–Barr virus associated post-transplant Hodgkin lymphoma in an adult patient after cord blood stem cell transplantation for acute lymphoblastic leukemia. J Clin Exp Hematop. 2009;49:45–51.
Krishnamurthy S, Hassan A, Frater JL, Paessler ME, Kreisel FH. Pathologic and clinical features of Hodgkin lymphoma—like posttransplant lymphoproliferative disease. Int J Surg Pathol. 2010;18:278–85.
Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, et al. Epstein–Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma. Int J Hematol. 2012;95:214–6.
Basso S, Zecca M, Calafiore L, Rubert L, Fiocchi R, Paulli M, et al. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein–Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Pediatr Transpl. 2013;17:E168–73.
Salh OS, Nadhem ON, Thakore SR, Halloush RA, Khasawneh FA. A 47-year-old stem cell transplant recipient with fever, cough and chest pain. Can Respir J. 2015;22:144–6.
Le J, Durand CM, Agha I, Brennan DC. Epstein–Barr virus and renal transplantation. Transpl Rev (Orlando). 2017;31:55–60.
Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH Jr. Quantitative Epstein–Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clin Transpl. 2012;26:741–7.
Stein H, Pileri SA, Weiss LM, Poppema S, Gascoyne RD, Jaffe ES. Hodgkin lymphomas, introduction. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 424–30.
Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Appl Immunohistochem Mol Morphol. 2009;17:96–101.
Jiang Y, Chen Y, Huang R, Chen G. Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis. Int J Hematol. 2016;104:413–9.
Hernandez O, Oweity T, Ibrahim S. Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4/CD8 ratio. Cytojournal. 2005;2:14.
Roshal M, Wood BL, Fromm JR. Flow cytometric detection of the classical Hodgkin lymphoma: clinical and research applications. Adv Hematol. 2011;2011:387034.
Acknowledgements
The authors thank Mr. Ben Phillis, Wakayama Medical University, for proofreading and editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have nothing to disclose.
About this article
Cite this article
Mohri, T., Ikura, Y., Hirakoso, A. et al. Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall. Int J Hematol 108, 218–227 (2018). https://doi.org/10.1007/s12185-018-2410-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-018-2410-x